A Comparison Between the TEG® 6s and TEG® 5000 Analyzers to Assess Coagulation in Trauma Patients.
Trauma-induced coagulopathy is a major driver of mortality following severe injury. Viscoelastic goal-directed resuscitation can reduce mortality after injury. The TEG® 5000 system is widely used for viscoelastic testing. However, the TEG® 6s system incorporates newer technology, with encouraging results in cardiovascular interventions. The purpose of this study was to validate the TEG® 6s system for use in trauma patients. Multicenter noninvasive observational study for method comparison conducted at 12 US Level I and II trauma centers. Agreement between the TEG® 6s and TEG® 5000 systems was examined using CK.R, CFF.MA, CK.LY30, CRT.MA and CK.MA parameters in adults meeting full or limited trauma team criteria. Blood was drawn ≤1hr after admission. Assays were repeated in duplicate. Reliability (TEG® 5000 vs. TEG® 6s analyzers) and repeatability (inter-device comparison) was quantified. Linear regression was used to define the relationship between TEG® 6s and TEG® 5000 devices. A total of 475 patients were enrolled. The cohort was predominantly male (68.6%) with a median age of 49 years. Regression line slope estimates (ß) and linear correlation estimates (p) were as follows: CK.R (ß=1.05,p=0.9), CFF.MA (ß=0.99,p=0.95), CK.LY30 (ß=1.01,p=0.91), CRT.MA (TEG® 6s) vs. CK.MA (TEG® 5000) (ß=1.06,p=0.86) as well as vs. CRT.MA (TEG® 5000) (ß=0.93,p=0.93), indicating strong reliability between the devices. Overall, within-device repeatability was better for TEG® 6s vs. TEG® 5000, particularly for CFF.MA and CK.LY30. The TEG® 6s device appears to be highly reliable for use in trauma patients, with close correlation to the TEG® 5000 device and equivalent/improved within-device reliability. Given the potential advantages of using the TEG® 6s device at the site of care, confirmation of agreement between the devices represents an important advance in diagnostic testing. Level II-Diagnostic test.